CIK: 0001977548 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $196,481 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 92,500 | $56,888 | 29.0% | $400.24 | — | SPONSORED ADR | 04016X101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 727,982 | $40,752 | 20.7% | $35.60 | +55.1% | COM | 76243J105 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 2,274,157 | $18,466 | 9.4% | $11.69 | +5.9% | COM | 71722W107 |
| AXSM | AXSOME THERAPEUTICS INC | 174,769 | $14,787 | 7.5% | $70.77 | +29.9% | COM | 05464T104 |
| IRON | DISC MEDICINE INC | 185,000 | $11,729 | 6.0% | $56.34 | +2.7% | COM | 254604101 |
| — | AVADEL PHARMACEUTICALS PLC | 1,004,790 | $10,560 | 5.4% | $14.06 | — | COM SHS | G29687103 |
| RVMD | REVOLUTION MEDICINES INC | 210,000 | $9,185 | 4.7% | $50.47 | 0.0% | COM | 76155X100 |
| PLRX | PLIANT THERAPEUTICS INC | 535,494 | $7,052 | 3.6% | $13.01 | +5.0% | COM | 729139105 |
| TCRX | TSCAN THERAPEUTICS INC | 1,755,987 | $5,338 | 2.7% | $5.24 | -13.5% | COM | 89854M101 |
| — | CIDARA THERAPEUTICS INC | 196,949 | $5,114 | 2.6% | $12.75 | — | COM NEW | 171757206 |
| TRVI | TREVI THERAPEUTICS INC | 1,084,135 | $4,467 | 2.3% | $2.81 | +13.8% | COM | 89532M101 |
| STOK | STOKE THERAPEUTICS INC | 305,387 | $3,368 | 1.7% | $13.25 | -7.3% | COM | 86150R107 |
| SLNO | SOLENO THERAPEUTICS INC | 70,027 | $3,148 | 1.6% | $47.00 | +10.2% | COM | 834203309 |
| KYMR | KYMERA THERAPEUTICS INC | 77,535 | $3,119 | 1.6% | $45.17 | 0.0% | COM | 501575104 |
| ATYR | ATYR PHARMA INC | 432,561 | $1,566 | 0.8% | $1.40 | +116.3% | COM NEW | 002120202 |
| CYTK | CYTOKINETICS INC | 20,000 | $941 | 0.5% | $47.79 | +8.7% | COM NEW | 23282W605 |